Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Paroxetine hydrochloride equivalent to 20 mg paroxetine base Tablet Les Laboratories Beecham, Mayenne, France and SmithKline Beecham Pharmaceuticals, Manor Royal, Crawley, Sussex, England Aropax 20 Mesalazine 1% w/v in 100 mL Enema Tillotts Pharma AG., Ziefen, Switzerland Asacol Ifosfamide 500 mg, 1 g, 2 g, 3 g Injecton, powder for, vial Asta Medica AG., Halle-Kunsebeck, Germany Holoxan Lyophilisate Leuprorelin acetate 3.75 mg and diluent Injection, Powder for, vial: Diluent, ampoule Takeda Chemical Industries Limited (Shonan plant), Fugisawa-shi, Japan Lucrin Depot Ketoconazole 10 mg/g in 60 mL, 100 mL Shampoo, bottle Janssen Cilag SpA., Borgo S. Michele, Latina, Italy Nizoral Ketoconazole 10 mg/g in 6 mL Shampoo, sachet Janssen Cilag SpA., Borgo S. Michele, Latina, Italy Nizoral Lignocaine hydrochloride 2.13% equivalent to 2% lignocaine in 200 mL Liquid, oral Astra Pharmaceuticals Pty Limited, North Ryde, New South Wales, Australia Xylocaine Viscous Dated this 16th day of May 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.